Dr Arteaga on CDK4/6 Inhibitor Resistance in ER+ Breast Cancer
Carlos Arteaga, MD, discusses the resistance to CDK4/g inhibitors in hormone receptor–positive breast cancer.
Source: onclive.com
Lisak Simmons News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lisak Simmons. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lisak Simmons Today - Breaking & Trending Today
Breaking Down the Utility of Vepdegestrant in First-Line ER+/HER2– Breast Cancer
Carlos L. Arteaga, MD, discusses the utility of vepdegestrant alone or in combination in patients with ER-positive, HER2-negative advanced breast cancer.
Source: onclive.com
Valhi : 2023 Proxy Statement | MarketScreener
VALHI, INC. Three Lincoln Centre 5430 LBJ Freeway, Suite 1700 Dallas, Texas 75240-2620 April 5,... | April 10, 2023
Source: marketscreener.com
$20 Million in CPRIT Cancer Research Funds Heading to North Texas
UT Dallas received $6 million to recruit an established researcher from the University of Rochester.
Source: dmagazine.com
Inspired By - People Newspapers
As part of the 2023 Remarkable Women coverage, we asked each featured woman to tell us about a remarkable woman in their lives.
Source: peoplenewspapers.com